BC Special Seminar: January 24, 2024
"Application of highly immunodeficient mice for cancer research and drug development" by Professor Seiji Okada, MD, PhD "Establishment and application ...
BC Special Seminar: January 15, 2024
BC Special Seminar “Science Careers in Pharma Beyond the Bench” by Chatarin (Chad) Wangsanuwat, Ph.D. University of California, Santa Barbara ...
BC Special Seminar: January 24, 2024
BC Special Seminar “Science Careers in Pharma Beyond the Bench” by Dr. Oleg Lavrukhin Regional Field Medical Lead Sanofi US ...
BC Faculty Seminar: January 10, 2024
BC Faculty Seminar “Development of smart nano-delivery platforms targeting colorectal cancer for personalized medicine: A showcase of ZY-444 small molecule ...
Research Highlights
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation
Cholangiocarcinoma (CCA) is a difficult-to-treat cancer, with limited therapeutic options and surgery being the only curative treatment. Standard chemotherapy involves ...
Targeting MYC at the intersection between cancer metabolism and oncoimmunology
MYC activation is a known hallmark of cancer as it governs the gene targets involved in various facets of cancer ...